Form 4: VolitionRx Secretary Rodney Rootsaert Reports Acquisition of Restricted Stock Units

Rodney Rootsaert, Secretary of VolitionRx, reports the acquisition of 7,908 restricted stock units (RSUs) in lieu of cash compensation.

Summary

• On March 1, 2025, Rodney Gerard Rootsaert, Secretary of VolitionRx, was awarded 7,908 restricted stock units (RSUs) under the Issuer's 2024 Stock Incentive Plan.
• These RSUs were granted in lieu of cash compensation.
• The RSUs vest in three equal installments of 2,636 units on March 1, 2025, April 1, 2025, and May 1, 2025, respectively.
• The RSUs are also subject to further time-based vesting in a single installment on March 1, 2026, and are generally subject to continued service throughout each applicable vesting date.
• Upon vesting and settlement, the reporting person will receive shares of common stock equal to the number of RSUs that have vested.
• Rootsaert also indirectly owns 1,007,718 shares of common stock through Concord International, Inc., where he is a controlling director.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing compensation.

Positives

• The acquisition of RSUs by a company officer can be seen as a positive sign, aligning the officer's interests with those of the shareholders.

Future Outlook

The reporting person will receive shares of common stock equal to the number of RSUs that have vested upon vesting and settlement.

Industry Context

Form 4 filings are a routine part of regulatory compliance for publicly traded companies, providing transparency into the transactions of company insiders.

Stakeholder Impact

• The granting of RSUs aligns the interests of the reporting person with those of the shareholders.

Key Dates